Evidence map›Paper›PMID 22766852›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2012

Suppression of IL-8 production in gastric epithelial cells by MUC1 mucin and peroxisome proliferator-associated receptor-γ.

Yong Sung Park, Wei Guang, Thomas G Blanchard, K Chul Kim, Erik P Lillehoj

Abstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. EnteroaggregativemBio · 2017
    Article
  4. Review
  5. Article
  6. Mucin 1 gene (MUC1) and gastric-cancer susceptibility.International journal of molecular sciences · 2014
    Article
  7. Genetic regulation of MUC1 expression by Helicobacter pylori in gastric cancer cells.Biochemical and biophysical research communications · 2014
    Article
  8. Article
  9. Journal of pediatric biochemistry · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yong Sung ParkDepartment of Physiology and Lung Center, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
Wei Guang
Thomas G Blanchard
K Chul Kim
Erik P Lillehoj
University of Maryland, Baltimore · USTemple Lung Center · USTemple University · US

Funding

SIGNALING MECHANISM OF MUC1 MUCINR01HL047125 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI KIM, KWANG CHUL · 1991 to 2015
$4.5M
Anti-inflammatory role of MUC1 mucinR01HL081825 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI KIM, KWANG CHUL · 2006 to 2010
$2.2M
Counter-Regulation of TLR-Driven Mucosal InflammationR21AI083463 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LILLEHOJ, ERIK P · 2009 to 2010
$375k
NHLBI NIH HHS HL-47125NHLBI NIH HHS HL-81825NHLBI NIH HHS R01 HL047125NIAID NIH HHS AI-83463
6 · The paper itself

Abstract

MUC1 is a membrane-tethered mucin expressed on the apical surface of epithelial cells. Our previous report (Guang W, Ding H, Czinn SJ, Kim KC, Blanchard TG, Lillehoj EP. J Biol Chem 285: 20547-20557, 2010) demonstrated that expression of MUC1 in AGS gastric epithelial cells limits Helicobacter pylori infection and reduces bacterial-driven IL-8 production. In this study, we identified the peroxisome proliferator-associated receptor-γ (PPARγ) upstream of MUC1 in the anti-inflammatory pathway suppressing H. pylori- and phorbol 12-myristate 13-acetate (PMA)-stimulated IL-8 production. Treatment of AGS cells with H. pylori or PMA increased IL-8 levels in cell culture supernatants compared with cells treated with the respective vehicle controls. Prior small interfering (si)RNA-induced MUC1 silencing further increased H. pylori- and PMA-stimulated IL-8 levels compared with a negative control siRNA. MUC1-expressing AGS cells pretreated with the PPARγ agonist troglitazone (TGN) had reduced H. pylori- and PMA-stimulated IL-8 levels compared with cells treated with H. pylori or PMA alone. However, following MUC1 siRNA knockdown, no differences in IL-8 levels were seen between TGN/H. pylori and H. pylori-only cells or between TGN/PMA and PMA-only cells. Finally, TGN-treated AGS cells had increased Muc1 promoter activity, as measured using a Muc1-luciferase reporter gene, and greater MUC1 protein levels by Western blot analysis, compared with vehicle controls. These results support the hypothesis that PPARγ stimulates MUC1 expression by AGS cells, thereby attenuating H. pylori- and PMA-induced IL-8 production.

Indexed as

ChromansEnzyme-Linked Immunosorbent AssayEpithelial CellsGene DeletionGene Expression RegulationHelicobacter pyloriHumansInterleukin-8Phorbol 12,13-DibutyratePPAR gammaPromoter Regions, GeneticStomachThiazolidinedionesTroglitazoneChromansInterleukin-8Phorbol 12,13-DibutyratePPAR gammaThiazolidinedionesTroglitazone

Identifiers

PMID22766852
PMCPMC3468531
OpenAlexW1990953415

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.